46122
45014
S&P/TSX
15349.04
+56.07
+0.37%
S&P-CDNX
780.32
+2.62
+0.34%
S&P-500
2506.54
-0.11
-0.00%
NASDAQ
6454.443
-6.880
-0.106%
Dow
22370.69
-0.11
(0.00%)
Dollar
0.8152
+0.0017
+0.2090%
Oil
50.00
+0.52
+1.05%
Gold
1312.60
+5.90
+0.45%
Silver
17.27
+0.08
+0.44%


Valeant to sell Obagi

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.



More Business News

45757
Recent Trending
44548
45406
Castanet Proud Member of RTNDA Canada
45406
Press Room
45751